{"filings":[{"id":1304476,"accession_number":"0001114483-26-000024","cik":1114483,"company_name":"Integer Holdings Corp","ticker":"ITGR","form_type":"8-K","filed_at":"2026-06-26T20:18:34+00:00","items":["5.02"],"status":"ready","headline":"Integer Holdings EVP Stephens transitions to Special Projects role until March 31, 2027","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Jim Stephens transitions from President CRM & Neuromodulation to EVP Special Projects effective June 29, 2026.","The role ends March 31, 2027, unless earlier terminated by Stephens or the Company.","Stephens will not be eligible for short-term or long-term incentive awards in 2027.","If a Change of Control occurs before termination, his separation on March 31, 2027 is treated as termination without cause."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":3020962237.5853114,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":609839,"accession_number":"0001114483-26-000021","cik":1114483,"company_name":"Integer Holdings Corp","ticker":"ITGR","form_type":"8-K","filed_at":"2026-05-22T20:17:17+00:00","items":["5.02","5.07","9.01"],"status":"ready","headline":"Integer Holdings approves 2026 Omnibus Incentive Plan and retention bonuses for CEO and top executives","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Stockholders approved the 2026 Omnibus Incentive Plan, adding 1,000,000 new shares plus carryover from prior plan.","Retention bonuses of $1.75M for CEO Payman Khales; $980k for Diron Smith; $816.75k for Lindsay Blackwood; $408k for Andrew Senn; $451.35k for Jim Stephens.","CEO employment agreement amended: upon termination without cause or good reason near change of control, performance equity vests at greater of target and actual.","Change of Control Agreements for four other named executives amended similarly, applying to termination within 24 months following a change of control.","All 11 directors elected, Deloitte & Touche ratified as auditor, and say-on-pay approved at the annual meeting."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":3020962237.5853114,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":91377,"accession_number":"0001171843-26-002878","cik":1114483,"company_name":"Integer Holdings Corp","ticker":"ITGR","form_type":"8-K","filed_at":"2026-04-30T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Integer reports Q1 sales $440M (+0.5%), adj EPS $1.20; board starts strategic review","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Q1 sales $440M (+0.5% reported, +1.3% organic); GAAP op income $32M (-36%), adj op income $61M (-14%).","Non-GAAP adj EPS $1.20 (-8% YoY); adjusted EBITDA $85M (-7%).","2026 outlook lowered: sales $1.805-1.835B (down 3-1% YoY), adj EPS $5.83-6.40 (down 9%-0%).","Cardio & Vascular sales $262M (+1%); CRMN $168M (+5%); Other $10M (decline from portable medical exit).","Board initiates strategic review to consider sale/merger; Goldman Sachs & Davis Polk as advisors; no deadline set."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":3020962237.5853114,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":101411,"accession_number":"0001171843-26-001505","cik":1114483,"company_name":"Integer Holdings Corp","ticker":"ITGR","form_type":"8-K","filed_at":"2026-03-12T23:59:59+00:00","items":["1.01","5.02","7.01","9.01"],"status":"ready","headline":"Integer Holdings adds two directors, cuts board size, in Irenic Capital cooperation deal","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["James Flanagan and Aaron Kapito appointed to Board effective March 12, 2026 as part of cooperation agreement with Irenic Capital Management.","Two incumbent directors will not stand for re-election at 2026 Annual Meeting; Board size capped at 13 then reduced to 11.","Irenic agreed to standstill, voting commitments, and withdrawal of director nominations for 2026 Annual Meeting.","Kapito to serve on Technology Strategy and Compensation Committees; Flanagan on Audit and Technology Strategy.","Cooperation period runs until 30 days before 2027 advance notice deadline or one year anniversary."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":3020962237.5853114,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":101410,"accession_number":"0001171843-26-000921","cik":1114483,"company_name":"Integer Holdings Corp","ticker":"ITGR","form_type":"8-K","filed_at":"2026-02-19T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Integer reports Q4 adjusted EPS $1.76, 23% YoY growth; full year adjusted EPS $6.40, up 21%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 sales $472M (+5% YoY); GAAP EPS $1.38, adjusted EPS $1.76 (+23%).","FY25 sales $1.854B (+8%); GAAP EPS $2.89 (-15%), adjusted EPS $6.40 (+21%).","Cardio & Vascular sales grew 11% Q4; Cardiac Rhythm Mgmt & Neuromodulation down 2% Q4.","Initiates $50M accelerated share repurchase under existing $200M board authorization.","2026 outlook: sales $1.826B-$1.876B (flat YoY); adjusted EPS $6.29-$6.78 (down 2% to up 6%)."],"consensus_eps_estimate":null,"consensus_eps_actual":2.89,"consensus_revenue_estimate":null,"consensus_revenue_actual":1853637000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":3020962237.5853114,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":117777,"accession_number":"0001171843-25-006942","cik":1114483,"company_name":"Integer Holdings Corp","ticker":"ITGR","form_type":"8-K","filed_at":"2025-11-04T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Integer Holdings authorizes $200M share repurchase program, no expiration date","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board approved up to $200M of common stock repurchases on Nov 3, 2025.","Funding from cash on hand and free cash flows; no fixed expiration date.","Repurchases may occur on open market or in private deals at management discretion.","CEO Payman Khales cites confidence in strategy and strong free cash flow generation."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":3020962237.5853114,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":117776,"accession_number":"0001171843-25-006651","cik":1114483,"company_name":"Integer Holdings Corp","ticker":"ITGR","form_type":"8-K","filed_at":"2025-10-24T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Payman Khales becomes Integer President and CEO, succeeding retiring Joseph Dziedzic","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Khales appointed CEO and board member effective Oct. 24, 2025; Dziedzic serves as advisor through March 31, 2026.","Employment agreement sets $875,000 base salary, 100% target STI bonus, and 2026 LTI target not less than $5M.","Khales receives special grant of $550,000 in service-based RSUs vesting ratably over three years.","Khales joined Integer in 2018, doubled Cardio & Vascular sales in seven years as President before COO role."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":3020962237.5853114,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":117775,"accession_number":"0001171843-25-006618","cik":1114483,"company_name":"Integer Holdings Corp","ticker":"ITGR","form_type":"8-K","filed_at":"2025-10-23T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Integer Q3 sales up 8% to $468M; non-GAAP EPS $1.79, up 25% YoY; updates 2025 outlook","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP diluted EPS from continuing ops $1.11 (+10% YoY); non-GAAP adjusted EPS $1.79 (+25%).","Non-GAAP adjusted operating income $86M (+14%); adjusted EBITDA $106M (+11%).","Cardio & Vascular sales up 15% YoY; Other Markets down 16% on planned portable medical exit.","Total debt increased $204M to $1.194B, primarily for acquisitions and convertible note offering.","2025 sales guidance raised to $1.84-1.854B (7-8% growth); adjusted EPS outlook $6.29-6.43."],"consensus_eps_estimate":null,"consensus_eps_actual":1.52,"consensus_revenue_estimate":null,"consensus_revenue_actual":1381577000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":3020962237.5853114,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":134217,"accession_number":"0001171843-25-004663","cik":1114483,"company_name":"Integer Holdings Corp","ticker":"ITGR","form_type":"8-K","filed_at":"2025-07-24T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Integer Holdings Q2 2025 Sales Up 11% to $476M, Raises Full-Year Profit Outlook","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Sales increased 11% to $476 million in Q2 2025, driven by strong Cardio & Vascular growth of 24%.","GAAP operating income rose 9% to $59 million; adjusted operating income up 15% to $81 million.","Adjusted EPS grew 19% to $1.55; GAAP diluted EPS up 18% to $1.04.","Adjusted EBITDA up 10% to $99 million; total debt rose to $1.202 billion from acquisitions and convertible note.","Company raised 2025 outlook: adjusted operating income growth 12%–16%, adjusted EPS growth 18%–23%."],"consensus_eps_estimate":null,"consensus_eps_actual":0.41,"consensus_revenue_estimate":null,"consensus_revenue_actual":913886000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.9,"calibrated_materiality_score":0.9,"market_cap_usd":3020962237.5853114,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":134216,"accession_number":"0001171843-25-004406","cik":1114483,"company_name":"Integer Holdings Corp","ticker":"ITGR","form_type":"8-K","filed_at":"2025-07-10T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Integer appoints Michael Coyle to Board; brings 40+ years medtech leadership","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Michael Coyle appointed to Integer's Board of Directors effective July 10, 2025.","Coyle most recently served as president/CEO of iRhythm Technologies; prior roles at Medtronic, St. Jude Medical, and Eli Lilly.","He will serve on Audit, Compensation & Organization, and Technology Strategy Committees.","Board size increased to 11 directors; Coyle's term runs until next annual meeting.","Coyle holds a Wharton MBA and six U.S. patents related to cardiovascular medical devices."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":3020962237.5853114,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":134215,"accession_number":"0001171843-25-004295","cik":1114483,"company_name":"Integer Holdings Corp","ticker":"ITGR","form_type":"8-K","filed_at":"2025-07-02T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Integer notifies holders of 2.125% convertible notes due 2028 of conversion period starting July 1, 2025","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Notes convertible July 1–Sept 30, 2025, at option of holders after stock price condition met.","Conversion price approx. $87.20/share (rate: 11.4681 shares per $1,000 principal).","Condition triggered: last sale price >130% of conversion price for 20+ trading days in Q2 2025.","Settlement: cash up to principal amount; excess in cash, shares, or mix at company's election.","Company makes no recommendation to holders; conversion agent is Wilmington Trust."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":3020962237.5853114,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":151004,"accession_number":"0001114483-25-000116","cik":1114483,"company_name":"Integer Holdings Corp","ticker":"ITGR","form_type":"8-K","filed_at":"2025-05-28T23:59:59+00:00","items":["5.03","5.07","9.01"],"status":"ready","headline":"Integer Holdings shareholders approve officer exculpation amendment; bylaws amended","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Shareholders approved officer exculpation amendment to Certificate of Incorporation (27.5M for, 5.1M against); filed with Delaware on May 23.","Board amended Bylaws to delete Article 9 (ratification of prior actions), effective May 21.","All 10 director nominees elected with >32M votes each; Deloitte ratified as auditor (97% for); say-on-pay passed (97% of votes cast for)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":3020962237.5853114,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":151003,"accession_number":"0001171843-25-002483","cik":1114483,"company_name":"Integer Holdings Corp","ticker":"ITGR","form_type":"8-K","filed_at":"2025-04-24T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Integer Holdings CEO Joseph Dziedzic to retire Oct 24, 2025; COO Payman Khales named successor","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CEO Joseph Dziedzic will retire effective October 24, 2025; will serve as Special Advisor through March 31, 2026.","COO Payman Khales, age 55, appointed President and CEO effective Oct 24; will join Board same day.","Dziedzic receives base salary as Special Advisor, full vesting of RSUs and prorated PRSUs under retirement treatment.","Dziedzic's post-termination restrictive covenants extended from 24 to 36 months in exchange for release.","First quarter 2025 financial results reported separately; conference call scheduled today at 8 a.m. CT."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":3020962237.5853114,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":151002,"accession_number":"0001171843-25-002464","cik":1114483,"company_name":"Integer Holdings Corp","ticker":"ITGR","form_type":"8-K","filed_at":"2025-04-24T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Integer Q1 sales +7% to $437M, adjusted EPS $1.31; raises 2025 adjusted EPS outlook","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Sales $437M (+7% YoY), organic +6%; Cardio & Vascular +17%, Cardiac Rhythm Management & Neuromodulation +2%.","Non-GAAP adjusted net income $46M (+19%), adjusted EPS $1.31 (up $0.17).","GAAP net loss $22M from debt conversion inducement expense on $1.0B 1.875% convertible notes due 2030.","Closed $1.0B convertible note offering; total debt $1.235B, leverage ratio 3.3x adjusted EBITDA.","2025 outlook: sales $1.846-1.880B (8-10% growth); adjusted EPS $6.15-6.51 (16-23% growth, raised)."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.66,"consensus_revenue_estimate":null,"consensus_revenue_actual":437392000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":3020962237.5853114,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":151001,"accession_number":"0001171843-25-002154","cik":1114483,"company_name":"Integer Holdings Corp","ticker":"ITGR","form_type":"8-K","filed_at":"2025-04-11T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Integer says tariffs to have immaterial impact; $1-5M hit to FY adj. operating income","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Estimates $1-5M impact on full-year adjusted operating income from tariffs.","Assumes currently applicable tariffs and April 2 U.S. tariffs after 90-day pause.","Mitigation actions are incorporated into the estimate.","Q1 2025 earnings results scheduled for release on April 24, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":3020962237.5853114,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":151000,"accession_number":"0001114483-25-000068","cik":1114483,"company_name":"Integer Holdings Corp","ticker":"ITGR","form_type":"8-K","filed_at":"2025-04-02T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Integer announces conversion period for 2.125% Convertible Notes due 2028","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Notes convertible at holder's option from April 1 through June 30, 2025.","Conversion triggered by stock price exceeding 130% of $87.20 conversion price for 20 of 30 trading days ending March 31, 2025.","Conversion rate: 11.4681 shares per $1,000 principal; company can settle in cash, stock, or combination.","Principal amount of Notes is $400M (implied from 2.125% coupon); no stated change to terms."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":3020962237.5853114,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":169901,"accession_number":"0001171843-25-001541","cik":1114483,"company_name":"Integer Holdings Corp","ticker":"ITGR","form_type":"8-K","filed_at":"2025-03-19T23:59:59+00:00","items":["1.01","2.03","3.02","7.01","9.01"],"status":"ready","headline":"Integer closes $1B 1.875% convertible notes offering; expects ~$12M interest savings","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Closed $1B aggregate principal of 1.875% Convertible Senior Notes due 2030, upsized from $750M to $875M plus full $125M option.","Net proceeds ~$976.1M; used $71M for capped call transactions, exchanged ~$383.7M of 2028 notes for cash + 1.55M shares, repaid revolver and term A loan.","Capped call cap price $189.44 per share (60% premium over March 13 close of $118.40), mitigating potential dilution on conversion.","Expected to be immediately accretive to 2025 adjusted earnings from lower interest expense of ~$12 million.","Initial conversion rate 6.6243 shares/$1,000 (conversion price ~$150.96); interest payable semiannually at 1.875%."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":3020962237.5853114,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":169900,"accession_number":"0001171843-25-001475","cik":1114483,"company_name":"Integer Holdings Corp","ticker":"ITGR","form_type":"8-K","filed_at":"2025-03-14T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Integer Holdings prices $875M convertible notes at 1.875%, exchanges $383.7M of existing notes","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Priced $875M of 1.875% convertible senior notes due 2030, upsized from $750M.","Concurrent exchange of $383.7M of existing 2.125% notes for $384.4M cash and 1.6M shares.","Net proceeds ~$853.9M; $62.1M for capped call transactions; balance for debt repayment and general use.","Initial conversion price $150.96 (27.5% premium to $118.40 close); cap price $189.44 (60% premium).","Notes unsecured, mature March 15, 2030; expected closing March 18, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":3020962237.5853114,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":169899,"accession_number":"0001171843-25-001436","cik":1114483,"company_name":"Integer Holdings Corp","ticker":"ITGR","form_type":"8-K","filed_at":"2025-03-12T23:59:59+00:00","items":["1.01","2.03","7.01","8.01","9.01"],"status":"ready","headline":"Integer launches $750M convertible note offering due 2030, with $125M option","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Aggregate principal amount of $750M convertible senior notes due March 15, 2030; initial purchasers can buy up to $125M more.","Notes pay semi-annual interest; convertible into cash and/or common stock at Company's election.","Proceeds partly used to fund capped call transactions (anti-dilution) and to exchange existing 2.125% notes due 2028.","Fourth amendment to credit agreement permits up to $1.5B of convertible note indebtedness outstanding.","Remaining net proceeds to repay borrowings under credit agreement and for general corporate purposes."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":3020962237.5853114,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":169898,"accession_number":"0001114483-25-000052","cik":1114483,"company_name":"Integer Holdings Corp","ticker":"ITGR","form_type":"8-K","filed_at":"2025-02-28T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Integer director William B. Summers to retire at 2025 annual meeting, not seeking re-election","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["William B. Summers, Jr. will not stand for re-election and retires from the Board at the conclusion of his term effective with the 2025 annual meeting.","Summers' decision is not due to any disagreement with the company.","No replacement has been announced for the departing director."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":3020962237.5853114,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":169897,"accession_number":"0001171843-25-000959","cik":1114483,"company_name":"Integer Holdings Corp","ticker":"ITGR","form_type":"8-K","filed_at":"2025-02-20T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Integer Q4 sales +11% to $449M, adj EPS $1.43; 2025 guidance calls for 8-10% sales growth","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 sales $449M (+11% YoY), GAAP EPS $0.91 (+15%), adjusted EPS $1.43 (+1%).","Full year 2024 sales $1.717B (+10%), adjusted EPS $5.30 (+15%).","Acquired Precision Coating (~$152M) closed Jan 7, 2025; signed VSi Parylene (~$28M) expected close by end Feb 2025.","2025 outlook: sales $1.846-1.880B (8-10% growth), adjusted EPS $5.84-6.20 (10-17% growth).","Leverage ratio 2.6x at Dec 31, 2024; expects to stay within 2.5x-3.5x target after acquisitions."],"consensus_eps_estimate":null,"consensus_eps_actual":3.36,"consensus_revenue_estimate":null,"consensus_revenue_actual":1716596000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":3020962237.5853114,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":169896,"accession_number":"0001114483-25-000002","cik":1114483,"company_name":"Integer Holdings Corp","ticker":"ITGR","form_type":"8-K","filed_at":"2025-01-02T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Integer announces conversion period for 2.125% Convertible Senior Notes due 2028","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Notes convertible Jan 1–Mar 31, 2025 at 11.4681 shares per $1,000 principal (~$87.20/share).","Trigger: stock price >130% of conversion price for 20 of 30 trading days ending Dec 31, 2024.","Settlement: cash up to principal amount; cash/shares/combination for excess.","Company makes no recommendation; conversion procedures via DTC or Wilmington Trust."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":3020962237.5853114,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":186952,"accession_number":"0001171843-24-005802","cik":1114483,"company_name":"Integer Holdings Corp","ticker":"ITGR","form_type":"8-K","filed_at":"2024-10-24T23:59:59+00:00","items":["2.02","7.01","5.02","9.01"],"status":"ready","headline":"Integer Q3 sales +9% to $431M; raises FY outlook; promotes Khales to COO","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 sales $431M (+9% YoY), organic +4%; GAAP op income $58M (+19%), adj op income $76M (+17%).","GAAP diluted EPS $1.01; adj EPS $1.43; adj EBITDA $96M (+18%).","Raises FY 2024 adj op income midpoint to $280-288M (+18-22%); FY sales $1.707-1.727B (+10-11%).","Electrochem divestiture for $50M cash on track to close October 2024.","Khales promoted to COO, Senn to President Cardio & Vascular; both effective Q1 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":2.46,"consensus_revenue_estimate":null,"consensus_revenue_actual":1267099000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":3020962237.5853114,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":186951,"accession_number":"0001114483-24-000125","cik":1114483,"company_name":"Integer Holdings Corp","ticker":"ITGR","form_type":"8-K","filed_at":"2024-10-02T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Integer Holdings 2.125% convertible notes become convertible in Q4 2024 after stock price trigger","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Notes convertible Oct 1-Dec 31, 2024; conversion rate 11.4681 shares per $1,000 principal (~$87.20/share).","Trigger: stock price >130% of conversion price for 20 of 30 trading days ending Sep 30, 2024.","Settlement: cash up to principal amount; cash/shares combo at company's option for remainder.","Notes due 2028; CUSIP 45826H AB5."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":3020962237.5853114,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":203488,"accession_number":"0001171843-24-004129","cik":1114483,"company_name":"Integer Holdings Corp","ticker":"ITGR","form_type":"8-K","filed_at":"2024-07-25T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Integer Q2 2024 sales up 9% to $436M, GAAP EPS $0.88, adj. EPS $1.30; raises profit outlook","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Sales $436M (+9% YoY, organic +5%); GAAP net income $31M (+30%); adj. net income $45M (+17%).","GAAP diluted EPS $0.88 (+$0.17); non-GAAP adj. EPS $1.30 (+$0.16).","Adjusted EBITDA $91M, +19% YoY.","FY 2024 sales reaffirmed $1.735B-$1.770B (9%-11% growth); adj. op. income growth raised to 14%-21%.","Cardio & Vascular +11%, Cardiac Rhythm & Neuromodulation +9%, Advanced Surgical +4%; Electrochem down."],"consensus_eps_estimate":null,"consensus_eps_actual":1.47,"consensus_revenue_estimate":null,"consensus_revenue_actual":851007000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":3020962237.5853114,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":203487,"accession_number":"0001114483-24-000109","cik":1114483,"company_name":"Integer Holdings Corp","ticker":"ITGR","form_type":"8-K","filed_at":"2024-07-08T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Integer Holdings General Counsel to retire Jan 31, 2025; successor search underway","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["McAlister C. Marshall, II, SVP, General Counsel & Corporate Secretary, plans to retire effective Jan 31, 2025.","Retirement is not due to any disagreement with the Company on operations, policies or practices.","Marshall will assist transition until successor is appointed or the retirement date, whichever is earlier.","Company has commenced a search process to identify a successor to Marshall."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":3020962237.5853114,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":203486,"accession_number":"0001114483-24-000106","cik":1114483,"company_name":"Integer Holdings Corp","ticker":"ITGR","form_type":"8-K","filed_at":"2024-07-01T23:59:59+00:00","items":["1.01","2.03","8.01","9.01"],"status":"ready","headline":"Integer upsizes revolver by $300M to $800M; notes become convertible in Q3","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Increased revolving credit facility from $500M to $800M via third amendment to credit agreement dated July 1, 2024.","2.125% Convertible Senior Notes due 2028 become convertible during calendar quarter ending Sept 30, 2024, at rate of 11.4681 shares per $1,000 principal (conversion price ~$87.20/share).","Conversion triggered because stock price exceeded 130% of conversion price for 20 of 30 trading days ending June 30, 2024.","Company may settle conversions in cash, shares, or combination; principal repaid in cash.","CFO Diron Smith cited balance sheet strength and commitment to 2.5-3.5x debt leverage target."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":3020962237.5853114,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":219930,"accession_number":"0001114483-24-000086","cik":1114483,"company_name":"Integer Holdings Corp","ticker":"ITGR","form_type":"8-K","filed_at":"2024-05-23T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Integer Holdings annual meeting results: all director nominees elected, auditor ratified, say-on-pay approved","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["11 director nominees elected, including Sheila Antrum, Pamela Bailey, Cheryl Capps, Joseph Dziedzic, among others.","Ratification of Deloitte & Touche as independent auditor for FY2024: 31,546,744 FOR, 967,325 AGAINST.","Advisory vote on named executive officer compensation approved: 31,020,611 FOR, 628,696 AGAINST, 861,703 broker non-votes."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.0,"calibrated_materiality_score":0.0,"market_cap_usd":3020962237.5853114,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":219929,"accession_number":"0001171843-24-002222","cik":1114483,"company_name":"Integer Holdings Corp","ticker":"ITGR","form_type":"8-K","filed_at":"2024-04-25T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Integer Q1 sales up 10% to $415M, adjusted EPS $1.14; reiterates FY2024 outlook","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Sales of $415M (+10% YoY), organic growth 6%; GAAP net income $21M (+57%), diluted EPS $0.59.","Non-GAAP adjusted net income $39M (+33%), adjusted EPS $1.14 vs $0.87; adjusted EBITDA $81M (+22%).","Total debt $1.141B (up $181M) to finance Pulse acquisition; leverage ratio 3.4x adjusted EBITDA.","Cardio & Vascular sales +16%; Cardiac Rhythm & Neuromodulation +8%; Electrochem declined.","FY2024 outlook reaffirmed: sales $1.735-1.770B (9-11% growth), adjusted EPS $5.01-$5.43."],"consensus_eps_estimate":null,"consensus_eps_actual":0.59,"consensus_revenue_estimate":null,"consensus_revenue_actual":414805000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":3020962237.5853114,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":239678,"accession_number":"0001171843-24-000822","cik":1114483,"company_name":"Integer Holdings Corp","ticker":"ITGR","form_type":"8-K","filed_at":"2024-02-15T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Integer Q4 sales $413M (+11%), adj EPS $1.39; 2023 sales $1.6B (+16%); 2024 guidance 9-11% growth","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 sales $413M (+11% YoY), GAAP income $26M (+54%), adj EPS $1.39, adj EBITDA $86M.","Full-year 2023: sales $1.597B (+16%), adj EPS $4.67, adj EBITDA $309M (+21%).","C&V segment sales +20% in Q4 and full year; Electrochem sales -42% in Q4 on normalized run-rate.","Acquired Pulse Technologies for ~$140M (Jan 2024); 2023 sales $42.5M, adj EBITDA $11M, expected accretive.","2024 guidance: sales $1.735-1.770B (+9-11%), adj operating income +13-20%, adj EPS $5.01-$5.43."],"consensus_eps_estimate":null,"consensus_eps_actual":2.69,"consensus_revenue_estimate":null,"consensus_revenue_actual":1596673000.0,"consensus_period":"2023-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":3020962237.5853114,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":239677,"accession_number":"0001171843-24-000199","cik":1114483,"company_name":"Integer Holdings Corp","ticker":"ITGR","form_type":"8-K","filed_at":"2024-01-10T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Integer acquires Pulse Technologies for ~$140M; prelim FY2023 sales up 16% to ~$1.596B","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Preliminary Q4 2023 sales $411-413M (+10-11% YoY); full-year sales $1.595-1.597B (+16% YoY).","Acquired Pulse Technologies, a micro-machining contract manufacturer, for ~$140M plus contingent consideration.","Pulse had ~$42M sales and ~$11M adj. EBITDA in 2023; deal closed Jan 5, 2024 using revolving credit facility.","Integer expects deal to be accretive and stay within 2.5x-3.5x leverage target.","Conference call for full Q4/FY results scheduled Feb 15, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":3020962237.5853114,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":257188,"accession_number":"0001171843-23-006435","cik":1114483,"company_name":"Integer Holdings Corp","ticker":"ITGR","form_type":"8-K","filed_at":"2023-10-26T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Integer Q3 sales +18% to $405M, raises full-year outlook; acquires InNeuroCo for $42M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Sales $405M (+18% organic); GAAP EPS $0.81, adjusted EPS $1.27.","Adjusted EBITDA $81M (+28%); raised FY2023 sales outlook to $1,575-1,595M (+14-16%).","Acquired InNeuroCo assets for $42M (plus contingent consideration) on Oct 1; expects immediate EPS accretion.","Full-year adjusted EPS outlook raised to $4.47-$4.67 (15-20% growth)."],"consensus_eps_estimate":null,"consensus_eps_actual":1.91,"consensus_revenue_estimate":null,"consensus_revenue_actual":1183522000.0,"consensus_period":"2023-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":3020962237.5853114,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":257187,"accession_number":"0001114483-23-000028","cik":1114483,"company_name":"Integer Holdings Corp","ticker":"ITGR","form_type":"8-K","filed_at":"2023-10-10T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Integer Holdings appoints Diron Smith as permanent CFO effective Oct 9, 2023","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Smith promoted from Interim CFO to EVP & CFO after internal/external search.","Base salary $440K; target short-term incentive 70% of salary; max 200%.","Annual long-term incentive grants valued at $1.2M.","Smith joined Integer in Aug 2021; prior finance roles at Tiffany & Co., GE, KPMG.","No family relationships or material transactions with other executives."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":3020962237.5853114,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":274532,"accession_number":"0001114483-23-000026","cik":1114483,"company_name":"Integer Holdings Corp","ticker":"ITGR","form_type":"8-K","filed_at":"2023-09-14T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Integer EVP Jennifer Bolt departs immediately; stays through Nov 9 for transition","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Bolt stepped down as EVP, Global Operations and ESG, effective immediately at company's request due to position restructuring.","Will remain employed until November 9, 2023 to support transition of responsibilities.","Severance benefits ~$484,500 (annual salary plus medical insurance contributions), subject to signing separation agreement.","Separation treated as involuntary termination without cause under company plans.","No replacement named; role apparently eliminated or restructured."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":3020962237.5853114,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":274531,"accession_number":"0001171843-23-004707","cik":1114483,"company_name":"Integer Holdings Corp","ticker":"ITGR","form_type":"8-K","filed_at":"2023-07-27T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Integer Holdings Q2 sales up 14% to $400M, raises FY2023 outlook","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP diluted EPS $0.71 vs $0.62 prior year; adjusted EPS $1.14 vs $1.04.","Sales growth driven by Cardio & Vascular (+15%), Cardiac Rhythm (+13%), Advanced Surgical (+17%).","FY2023 sales outlook raised to 11-13% growth (midpoint 12%); adjusted operating income growth outlook raised to 17-21%.","Total debt increased to $985M due to $500M convertible notes and $35M capped call; leverage ratio 3.5x.","CEO cites improving supply chain and labor environment; strong customer demand across product lines."],"consensus_eps_estimate":null,"consensus_eps_actual":1.1,"consensus_revenue_estimate":null,"consensus_revenue_actual":778829000.0,"consensus_period":"2023-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":3020962237.5853114,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":291811,"accession_number":"0001114483-23-000022","cik":1114483,"company_name":"Integer Holdings Corp","ticker":"ITGR","form_type":"8-K","filed_at":"2023-05-25T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Integer Holdings shareholders elect 11 directors, ratify Deloitte, and approve say-on-pay frequency","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All 11 director nominees elected; votes for ranged from 27.0M to 30.7M shares.","Ratification of Deloitte & Touche as auditor: 30,792,084 for, 1,212,329 against.","Advisory vote on executive compensation approved: 29,514,394 for, 1,397,401 against.","Annual say-on-pay frequency selected: 28,739,224 votes for 1-year, 2,160,176 for 3-year.","Board will hold annual advisory votes on executive compensation until next required vote."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"market_cap_usd":3020962237.5853114,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":291810,"accession_number":"0001114483-23-000018","cik":1114483,"company_name":"Integer Holdings Corp","ticker":"ITGR","form_type":"8-K","filed_at":"2023-05-08T23:59:59+00:00","items":["5.02","7.01"],"status":"ready","headline":"Integer Holdings CFO departs; interim CFO named; 2023 guidance reaffirmed","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CFO Jason K. Garland separated May 8, 2023; no disagreement on financials or ethics.","VP-FP&A Diron Smith appointed Interim CFO; annual base salary $321,000 plus long-term incentive grants of $630,000.","Company begins internal and external search for permanent CFO.","2023 guidance reaffirmed: sales $1,470-$1,500M, adj. EPS $4.00-$4.30, adj. EBITDA $285-$296M."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":3020962237.5853114,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":291809,"accession_number":"0001171843-23-002611","cik":1114483,"company_name":"Integer Holdings Corp","ticker":"ITGR","form_type":"8-K","filed_at":"2023-04-27T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Integer Q1 sales up 22% to $379M; GAAP EPS $0.39, adjusted $0.87","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Sales $379M (+22% YoY, organic +21%); GAAP net income $13M (+15%).","Non-GAAP adjusted net income $29M (+11%); adjusted diluted EPS $0.87 vs $0.78.","Adjusted EBITDA $66M (+22%); leverage ratio 3.6x; total debt $1,002M.","2023 outlook: sales $1.47B-$1.50B (7-9% growth), adjusted EPS $4.00-$4.30.","Product lines all grew: Cardio/Vascular +20%, Cardiac/Neuro +18%, Advanced Surgical/Ortho/Portable +42%, Electrochem +63%."],"consensus_eps_estimate":null,"consensus_eps_actual":0.39,"consensus_revenue_estimate":null,"consensus_revenue_actual":378785000.0,"consensus_period":"2023-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":3020962237.5853114,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":312576,"accession_number":"0001114483-23-000006","cik":1114483,"company_name":"Integer Holdings Corp","ticker":"ITGR","form_type":"8-K","filed_at":"2023-02-28T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Integer Holdings CEO Dziedzic exercises 14,530 options; President Khales gets $2M RSU award","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["CEO Joe Dziedzic exercised options for 14,530 shares via $366,883 cash payment; no taxes withheld due to director origin pre-CEO role.","President Cardio & Vascular Payman Khales awarded $2M in time-based RSUs vesting Feb 24, 2026; previous Nov 2022 RSUs re-vested to same date.","Khales' annual base salary increased from $450k to $550k effective March 20, 2023.","Awards designed to retain Khales and incentivize stock price growth; modified vesting triggers pro-rata upon involuntary termination after CEO change."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":3020962237.5853114,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":312575,"accession_number":"0001171843-23-001009","cik":1114483,"company_name":"Integer Holdings Corp","ticker":"ITGR","form_type":"8-K","filed_at":"2023-02-16T23:59:59+00:00","items":["1.01","2.02","7.01","2.03","9.01"],"status":"ready","headline":"Integer Q4 sales +19% to $372M; adj. EPS $1.11; guides 2023 sales growth 7-9%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 sales $372M (+19% YoY); GAAP diluted EPS $0.51 (-15%); adjusted EPS $1.11 (+12%).","Full year 2022 sales $1.376B (+13%); adjusted EPS $3.88 (-5%); operating cash flow $116M.","2023 outlook: sales $1.47-1.50B (7-9% organic); adj. EPS $4.00-4.30; op. cash flow $180-200M.","Credit agreement amended: revolver capacity increased $100M to $500M; maturity extended to Feb 2028; LIBOR replaced with SOFR."],"consensus_eps_estimate":null,"consensus_eps_actual":1.99,"consensus_revenue_estimate":null,"consensus_revenue_actual":1376096000.0,"consensus_period":"2022-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":3020962237.5853114,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":312574,"accession_number":"0001171843-23-000696","cik":1114483,"company_name":"Integer Holdings Corp","ticker":"ITGR","form_type":"8-K","filed_at":"2023-02-06T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Integer Holdings issues $500M 2.125% convertible notes due 2028; repays existing debt","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Net proceeds of ~$485.4M; used to fully repay term B loan and revolver, and pay $35M for capped calls.","Notes bear 2.125% interest, mature Feb 2028; conversion price initially ~$87.20 per share.","Capped call transactions set cap price at ~$108.59 per share to reduce dilution.","Offering includes full exercise of $65M initial purchasers' option.","Credit facility remains available; proceeds also cover related fees and expenses."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":3020962237.5853114,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":312573,"accession_number":"0001171843-23-000543","cik":1114483,"company_name":"Integer Holdings Corp","ticker":"ITGR","form_type":"8-K","filed_at":"2023-01-30T23:59:59+00:00","items":["1.01","2.02","7.01","2.03","8.01","9.01"],"status":"ready","headline":"Integer Q4 preliminary sales up 18-19%; launches $375M convertible notes offering","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Preliminary Q4 sales $370-372M (+18-19% YoY); GAAP op income $36-37M (+25-29%).","Full-year 2022 sales $1.374-1.376B (+13%); adjusted op income $191-192M (+2-3%).","Launches $375M convertible notes due 2028 (+$56.25M option); proceeds to repay term B loan.","Amends credit agreement to allow notes and capped calls; leverage ratio 3.5-3.6x.","Exiting ~$40M Portable Medical sales over 4 years; retaining $30M in heart failure & cochlear."],"consensus_eps_estimate":null,"consensus_eps_actual":1.99,"consensus_revenue_estimate":null,"consensus_revenue_actual":1376096000.0,"consensus_period":"2022-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":3020962237.5853114,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":331093,"accession_number":"0001114483-22-000031","cik":1114483,"company_name":"Integer Holdings Corp","ticker":"ITGR","form_type":"8-K","filed_at":"2022-11-04T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Integer Holdings grants $1M RSUs each to CFO Jason Garland and Cardio & Vascular President Payman Khales","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["CFO Jason Garland and President, Cardio & Vascular Payman Khales each awarded $1M in time-based RSUs.","RSUs vest annually in equal installments over three years; grant date November 2, 2022.","Awards made under the 2021 Omnibus Incentive Plan to retain and incent leadership.","Grants designed to recognize contributions and drive future stock price growth."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":3020962237.5853114,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":331092,"accession_number":"0001171843-22-006796","cik":1114483,"company_name":"Integer Holdings Corp","ticker":"ITGR","form_type":"8-K","filed_at":"2022-10-27T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Integer Q3 sales up 12% to $343M; GAAP net income down 27% to $16M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Sales increased 12% to $343M; GAAP EPS $0.48 vs $0.66 prior year; adjusted EPS $0.95 vs $1.05.","Cardio & Vascular sales +14%; Cardiac Rhythm Management +8%; Advanced Surgical +17%; Electrochem +24%.","2022 outlook: GAAP sales $1.35-1.38B, adj. EBITDA $244-260M, adj. EPS $3.57-3.97; organic growth 4-6%.","Total debt rose $111M to $939M due to Aran Biomedical acquisition for $129M; leverage ratio 3.8x.","CEO expects 2023 revenue growth of 7-9% with margin expansion; supply chain delays to be recovered in 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":1.45,"consensus_revenue_estimate":null,"consensus_revenue_actual":1003673000.0,"consensus_period":"2022-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":3020962237.5853114,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":331091,"accession_number":"0001114483-22-000026","cik":1114483,"company_name":"Integer Holdings Corp","ticker":"ITGR","form_type":"8-K","filed_at":"2022-10-11T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Integer Holdings President of Cardiac Rhythm Management & Neuromodulation resigns","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Joel Becker resigned as President, Cardiac Rhythm Management & Neuromodulation, effective Oct 7, 2022.","No replacement or interim successor has been announced by Integer Holdings.","Becker's departure is effective immediately after the notice date of Oct 6, 2022."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":3020962237.5853114,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":331090,"accession_number":"0001171843-22-006446","cik":1114483,"company_name":"Integer Holdings Corp","ticker":"ITGR","form_type":"8-K","filed_at":"2022-10-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Integer cuts FY2022 guidance on supplier delivery issues; Q3 prelim sales $342-344M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 preliminary sales $342-344M; GAAP operating income $25-30M; GAAP diluted EPS $0.38-0.51.","Full-year sales guidance lowered to $1.35-1.38B (from $1.37-1.395B); GAAP operating income $111-127M (from $136-148M).","Adjusted EPS guidance cut to $3.57-3.97 (from $4.20-4.50) due to $15M sales hit from three suppliers.","Company reduced SG&A by ~$8M annualized; expects positive price in 2023; preliminary 2023 sales growth 7-9%.","Supply chain challenges deteriorating; added 5% more direct labor in Q3 but three suppliers missed commitments."],"consensus_eps_estimate":null,"consensus_eps_actual":1.45,"consensus_revenue_estimate":null,"consensus_revenue_actual":1003673000.0,"consensus_period":"2022-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":3020962237.5853114,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":348651,"accession_number":"0001171843-22-005089","cik":1114483,"company_name":"Integer Holdings Corp","ticker":"ITGR","form_type":"8-K","filed_at":"2022-07-28T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Integer Q2 sales up 12% to $350M; GAAP net income falls 29%; raises FY2022 outlook","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 sales $350M (+12% YoY); GAAP net income $21M (-29%); Non-GAAP adj. net income $35M (-3%).","GAAP diluted EPS $0.62; Non-GAAP adj. diluted EPS $1.04, both down YoY.","Raises FY2022 sales outlook to $1.37-1.395B (12-14% growth); organic growth 6-8%.","Cardio & Vascular sales +25%; Electrochem -1% on supplier shortages.","Total debt $947M (+$119M) from Aran acquisition; leverage ratio 3.9x adjusted EBITDA."],"consensus_eps_estimate":null,"consensus_eps_actual":0.97,"consensus_revenue_estimate":null,"consensus_revenue_actual":660993000.0,"consensus_period":"2022-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":3020962237.5853114,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":365392,"accession_number":"0001114483-22-000018","cik":1114483,"company_name":"Integer Holdings Corp","ticker":"ITGR","form_type":"8-K","filed_at":"2022-05-18T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Integer Holdings annual meeting results: all 11 directors elected, auditor ratified, say-on-pay approved","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All 11 director nominees elected; highest withheld votes were 1.73M for Pamela Bailey.","Ratification of Deloitte as auditor: 30.45M for, 1.28M against, 10k abstentions.","Advisory say-on-pay approved: 29.94M for, 1.05M against, 14k abstentions (0.74M broker non-votes)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"market_cap_usd":3020962237.5853114,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":365391,"accession_number":"0001171843-22-002915","cik":1114483,"company_name":"Integer Holdings Corp","ticker":"ITGR","form_type":"8-K","filed_at":"2022-04-28T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Integer Q1 sales up 7% to $311M, adjusted EPS down 20%; guidance raised for Aran Biomedical acquisition","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Sales $311M (+7% YoY); GAAP net income $11M (-47%); adjusted net income $26M (-19%).","GAAP diluted EPS $0.34; non-GAAP adjusted EPS $0.78, down 20% YoY.","Acquired Aran Biomedical on April 6, 2022; adds ~$90M annualized sales at accretive growth.","FY2022 outlook: sales $1.36-1.38B (11-13% growth), adj. EBITDA $273-285M (12-17% growth).","Cardio & Vascular sales +13%; Cardiac Rhythm +1%; Electrochem +18%; Advanced Surgical -2%."],"consensus_eps_estimate":null,"consensus_eps_actual":0.34,"consensus_revenue_estimate":null,"consensus_revenue_actual":310912000.0,"consensus_period":"2022-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":3020962237.5853114,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":384992,"accession_number":"0001171843-22-001939","cik":1114483,"company_name":"Integer Holdings Corp","ticker":"ITGR","form_type":"8-K","filed_at":"2022-03-17T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Integer Chairman Bill Sanford to retire; Pamela Bailey named next Chair","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Bill R. Sanford retiring after 22 years on board, 14 as Chair, effective after May 18, 2022 annual meeting.","Pamela G. Bailey, board member since 2002 and former AdvaMed CEO, to become next Board Chair.","Board also rotated committee assignments as part of normal succession planning."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":3020962237.5853114,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":"2022-03-17T23:59:59+00:00|384992"}